Skip to content

Homoeopathic Medicines Bryonia alba 30C as a Prophylaxis for COVID-19

Effectiveness of Bryonia Alba 30C in the prevention of COVID-19 in Quarantine individual: Double Blind, Randomised Placebo Controlled Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025558
Enrollment
300
Registered
2020-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B338- Other specified viral diseases

Interventions

Intervention1: Bryonia alba 30C: Another half or 50 percentage of cases will receive Bryonia alba 30C as experiment arm. Homoeopathy intervention shall be taken twice (6 pills) daily of prescribed Hom

Sponsors

Principal Aarogya Homoeopathic Medical College and Hospital
Lead Sponsor
Ministry of AYUSH
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Persons in Quarantine centres with history of exposure, with all the following shall be included: 1. Suspected cases of COVID-19 who are asymptomatic. 2. Age 18 years and above and all genders 3. Willing to give written informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant women or lactating mothers 2. Immunocompromised individuals on basis of medical history 3. Symptomatic (similar to COVID-19) cases at quarantine facility. 4. Rapidly progressive respiratory failure and sepsis. 5. Aged below 18 yrs 6. Not willing to give informed consent

Design outcomes

Primary

MeasureTime frame
The results of the study will be able to determine the prophylactic effect of Homoeopathic Medicines in COVId-19 cases. If found effective, this could prove to be a Vital contribution in public health care for this Global Crisis of COVID-19.Timepoint: 1 week

Secondary

MeasureTime frame
Further, the cost-effectiveness of Homeopathy will enable developing countries in controlling such deadly disease effectively.Timepoint: 6 months

Countries

India

Contacts

Public ContactProf Dr Puneet R Shah

Aarogya Homoeopathic Medical College and Hospital

drdannih@gmail.com9636452755

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026